Abbott Laboratories (ABT) Return on Invested Capital (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 1.0% YoY), and the FY2025 full-year result was 0.03%, down 7.0% from the prior year.
• Return on Invested Capital eased to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.08% in Q2 2022 to a low of 0.01% in Q3 2023.
• A 5-year average of 0.02% and a median of 0.01% in 2025 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital dropped 7 bps in 2023 and grew 2 bps in 2025, its largest moves.
• Tracing ABT's Return on Invested Capital over 5 years: stood at 0.03% in 2022, then slumped by 71 bps to 0.01% in 2023, then soared by 142 bps to 0.02% in 2024, then decreased by 27 bps to 0.01% in 2025, then sank by 40 bps to 0.01% in 2026.
• Business Quant data shows ABT's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.03% in Q3 2025.